Chiesi Wins EU Nod For COPD Triple Combo, But Partner Is Predicted For Launch
Executive Summary
Chiesi's triple combination therapy for COPD, Trimbow, has secured its first approval globally after winning a positive recommendation from the CHMP for its use in Europe – but analysts expect a respiratory partner will be required to launch the product.